UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Restricted Share Units | 11/24/2011 | 11/24/2011 | Common Stock, no par value | 14,130 (1) | $ (2) | D | Â |
Stock Options (right to purchase) | Â (3) | 03/09/2014 | Common Stock, no par value | 150,000 | $ 10.86 | D | Â |
Restricted Share Units | 08/05/2014 | 08/05/2014 | Common Stock, no par value | 50,306 (4) | $ (2) | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Fibiger Hans Christian C/O BIOVAIL CORPORATION, 7150 MISSISSAUGA ROAD MISSISSAUGA, A6 L5N 8M5 |
 |  |  Chief Scientific Officer |  |
/s/ Angie Palmer, by Power of Attorney | 01/04/2010 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Includes an initial grant of 13,000 Restricted Share Units (granted on November 24, 2008) and additional Restricted Share Units that were allocated to the Reporting Person as dividend equivalents on the payment date(s) of dividends on Common Stock, no par value, of Biovail Corporation (the "Common Stock"). |
(2) | Each Restricted Share Unit represents a contingent right to receive one share of Common Stock. |
(3) | On March 9, 2009, the Reporting Person was granted 150,000 Stock Options which will vest and become exercisable in three equal annual installments commencing on the first anniversary of the grant date. |
(4) | Includes an initial grant of 50,000 performance based Restricted Share Units (granted on August 5, 2009) and additional units that were allocated to the Reporting Person as dividend equivalents on the payment date(s) of dividends on Common Stock. |
 Remarks: See Exhibit 24.1 - Power of Attorney |